BARCLAYS PLC

Position in VNDA — Vanda Pharmaceuticals Inc.

CIK 312069 LONDON, X0

Back to VNDA Full portfolio

Position in VNDA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$499,696

-$58,693 QoQ

Shares Held

81,650

+1.0% QoQ

Ownership

0.135%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#61

of 172 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in VNDA Over Time

Shares Held

Position Value (USD)

Derivatives in VNDA

reported options exposure · as of Mar 31, 2021

CallValue

CallShares

5,200

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,205,173 across 455 Biotechnology names. VNDA ranks #165 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	733,274	$364,239,192
2	REGN	Regeneron Pharmaceuticals, Inc.	256,192	$159,745,957
3	IONS	Ionis Pharmaceuticals Inc	1,603,136	$127,112,653
4	ARGX	Argenx SE	134,427	$124,717,337
5	MRNA	Moderna, Inc.	1,035,126	$72,489,872
6	BBIO	BridgeBio Pharma, Inc.	714,423	$53,210,224
7	TGTX	Tg Therapeutics, Inc.	957,848	$52,624,168
8	DNTH	Dianthus Therapeutics, Inc. /DE/	431,753	$42,087,281

All Filings in VNDA

Export CSV

42 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$499,696	81,650	+1.0%	Shares	Defined	2026-08-14
2026-03-31	$558,389	80,809	-57.7%	Shares	Defined	2026-05-15
2025-12-31	$1,684,937	191,036	-14.2%	Shares	Sole	2026-02-13
2025-09-30	$1,110,669	222,579	-0.8%	Shares	Sole	2026-03-31
2025-06-30	$1,059,186	224,404	+33.5%	Shares	Sole	2026-02-27
2025-03-31	$771,546	168,093	-5.8%	Shares	Sole	2026-03-17
2024-12-31	$854,382	178,368	+15.6%	Shares	Sole	2026-03-19
2024-09-30	$723,652	154,297	+128.2%	Shares	Sole	2026-03-31
2024-06-30	$382,053	67,620	-46.2%	Shares	Sole	2026-03-23
2024-03-31	$516,528	125,676	-26.8%	Shares	Sole	2026-03-24
2023-12-31	$724,312	171,638	+33.7%	Shares	Sole	2026-03-24
2023-09-30	$554,385	128,330	+2.6%	Shares	Sole	2026-03-26
2023-06-30	$824,178	125,065	+24.7%	Shares	Sole	2026-03-27
2023-03-31	$680,995	100,294	+3.7%	Shares	Sole	2026-03-30
2022-12-31	$714,938	96,744	-2.6%	Shares	Sole	2026-03-30
2022-09-30	$981,103	99,302	+443.9%	Shares	Sole	2022-11-03
2022-06-30	$199,011	18,258	-59.2%	Shares	Sole	2022-08-12
2022-03-31	$506,337	44,769	-37.5%	Shares	Sole	2022-05-16
2021-12-31	$1,124,047	71,641	+26.1%	Shares	Sole	2022-02-14
2021-09-30 ALXN	—	6	-100.0%	Shares	Sole	2021-11-09
2021-09-30	$973,586	56,802	+67.6%	Shares	Sole	2021-11-09
2021-06-30 ALXN	—	2,449,978	-31.5%	Shares	Sole	2021-08-13
2021-06-30	$728,972	33,890	-65.3%	Shares	Sole	2021-08-13
2021-03-31 ALXN	—	3,578,376	+877.3%	Shares	Sole	2021-05-13
2021-03-31 ALXN	—	5,200	-68.3%	Call	Sole	2021-05-13
2021-03-31	$1,467,422	97,698	+18.6%	Shares	Sole	2021-05-13
2020-12-31 ALXN	—	366,134	-10.4%	Shares	Sole	2021-02-11
2020-12-31 ALXN	—	16,400	+1071.4%	Call	Sole	2021-02-11
2020-12-31 ALXN	—	37,000	0.0%	Put	Sole	2021-02-11
2020-12-31	$1,082,590	82,389	-23.2%	Shares	Sole	2021-02-11
2020-09-30 ALXN	—	1,400	-99.2%	Call	Sole	2020-11-12
2020-09-30 ALXN	—	408,541	+73.0%	Shares	Sole	2020-11-12
2020-09-30 ALXN	—	37,000	-0.3%	Put	Sole	2020-11-12
2020-09-30	$1,036,604	107,309	+10.6%	Shares	Sole	2020-11-12
2020-06-30 ALXN	—	236,111	-38.7%	Shares	Sole	2020-08-12
2020-06-30 ALXN	—	167,800	-35.7%	Call	Sole	2020-08-12
2020-06-30 ALXN	—	37,100	-75.8%	Put	Sole	2020-08-12
2020-06-30	$1,110,125	97,039	+32.3%	Shares	Sole	2020-08-12
2020-03-31 ALXN	—	261,100	—	Call	Sole	2020-05-13
2020-03-31 ALXN	—	385,329	—	Shares	Sole	2020-05-13
2020-03-31 ALXN	—	153,400	—	Put	Sole	2020-05-13
2020-03-31	$759,895	73,349	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.